{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:26:05Z","timestamp":1793643965109,"version":"4.5.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012465","name":"Dalian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cca.2025.120816","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:54:20Z","timestamp":1767167660000},"page":"120816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Simultaneous quantification of acetylsalicylic acid, clopidogrel, ticagrelor and their major metabolites in human plasma by liquid chromatography\u2013tandem mass spectrometry"],"prefix":"10.1016","volume":"584","author":[{"given":"Wenqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciren","family":"Baima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cca.2025.120816_bb0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1517\/14656566.6.5.755","article-title":"Clopidogrel for the secondary prevention of stroke","volume":"6","author":"Diener","year":"2005","journal-title":"Expert. Opin. Pharmacother."},{"issue":"9038","key":"10.1016\/j.cca.2025.120816_bb0010","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cca.2025.120816_bb0015","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/clpt.2008.20","article-title":"The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance","volume":"84","author":"Kim","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.cca.2025.120816_bb0020","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"Jama"},{"issue":"20","key":"10.1016\/j.cca.2025.120816_bb0025","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","article-title":"Cytochrome P450 2C19 681G>a polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents","volume":"51","author":"Trenk","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.cca.2025.120816_bb0030","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1161\/01.CIR.0000134701.40946.30","article-title":"Clopidogrel resistance: a new chapter in a fast-moving story","volume":"109","author":"Wiviott","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2025.120816_bb0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/FTD.0b013e31815c13fd","article-title":"Determination of clopidogrel main metabolite in plasma: a useful tool for monitoring therapy?","volume":"30","author":"Mani","year":"2008","journal-title":"Ther. Drug Monit."},{"issue":"11","key":"10.1016\/j.cca.2025.120816_bb0040","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/dmd.30.11.1288","article-title":"Structure and stereochemistry of the active metabolite of clopidogrel","volume":"30","author":"Pereillo","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.cca.2025.120816_bb0045","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/bmc.973","article-title":"Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study of Astrix in Korean healthy volunteers","volume":"22","author":"Bae","year":"2008","journal-title":"Biomed. Chromatogr."},{"issue":"8","key":"10.1016\/j.cca.2025.120816_bb0050","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/bmc.2694","article-title":"Review of HPLC methods and HPLC methods with mass spectrometric detection for direct determination of aspirin with its metabolite(s) in various biological matrices","volume":"26","author":"Mullangi","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.cca.2025.120816_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jchromb.2012.03.010","article-title":"Simultaneous determination and pharmacokinetics of protein unbound aspirin and salicylic acid in rat blood and brain by microdialysis: an application to herbal-drug interaction","volume":"895-896","author":"Shaw","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120816_bb0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jchromb.2006.08.037","article-title":"Sensitive determination of aspirin and its metabolites in plasma by LC-UV using on-line solid-phase extraction with methylcellulose-immobilized anion-exchange restricted access media","volume":"846","author":"Yamamoto","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"13","key":"10.1016\/j.cca.2025.120816_bb0065","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/jssc.201000115","article-title":"Ultra-performance LC MS\/MS method for quantification of clopidogrel active metabolite","volume":"33","author":"Delavenne","year":"2010","journal-title":"J. Sep. Sci."},{"issue":"10","key":"10.1016\/j.cca.2025.120816_bb0070","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/j.1538-7836.2010.04004.x","article-title":"Is there really a relationship between the plasma concentration of the active metabolite of clopidogrel and the results of platelet function tests?","volume":"8","author":"Delavenne","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.cca.2025.120816_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jchromb.2012.11.005","article-title":"HPLC-MS\/MS method for the simultaneous determination of clopidogrel, its carboxylic acid metabolite and derivatized isomers of thiol metabolite in clinical samples","volume":"911","author":"Kara\u017aniewicz-\u0141ada","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/j.cca.2025.120816_bb0080","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00216-011-5147-4","article-title":"Development and validation of an HPLC-MS\/MS method to quantify clopidogrel acyl glucuronide, clopidogrel acid metabolite, and clopidogrel in plasma samples avoiding analyte back-conversion","volume":"401","author":"Silvestro","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"issue":"3","key":"10.1016\/j.cca.2025.120816_bb0085","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/bmc.3573","article-title":"Simultaneous quantitation of acetylsalicylic acid and clopidogrel along with their metabolites in human plasma using liquid chromatography tandem mass spectrometry","volume":"30","author":"Chhonker","year":"2016","journal-title":"Biomed. Chromatogr."},{"issue":"4","key":"10.1016\/j.cca.2025.120816_bb0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1755-5922.2009.00096.x","article-title":"Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist","volume":"27","author":"Husted","year":"2009","journal-title":"Cardiovasc. Ther."},{"issue":"21","key":"10.1016\/j.cca.2025.120816_bb0095","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1016\/j.bmcl.2007.07.057","article-title":"From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis","volume":"17","author":"Springthorpe","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.cca.2025.120816_bb0100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/dmd.110.037143","article-title":"In vitro evaluation of potential drug-drug interactions with ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential kinetics","volume":"39","author":"Zhou","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.cca.2025.120816_bb0105","first-page":"562","article-title":"Ticagrelor (brilinta), an antiplatelet drug for acute coronary syndrome","volume":"37","author":"Fuller","year":"2012","journal-title":"P t."},{"key":"10.1016\/j.cca.2025.120816_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2147\/TCRM.S19835","article-title":"Critical appraisal of ticagrelor in the management of acute coronary syndrome","volume":"7","author":"Nawarskas","year":"2011","journal-title":"Ther. Clin. Risk Manag."},{"issue":"6","key":"10.1016\/j.cca.2025.120816_bb0115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/jat\/bkw039","article-title":"Simultaneous determination of ticagrelor and its metabolites in human plasma and urine using liquid chromatography-tandem mass spectrometry","volume":"40","author":"Zhong","year":"2016","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.cca.2025.120816_bb0120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clinthera.2015.01.010","article-title":"Pharmacokinetics and pharmacodynamics of ticagrelor and prasugrel in healthy male Korean volunteers","volume":"37","author":"Jeon","year":"2015","journal-title":"Clin. Ther."},{"issue":"4","key":"10.1016\/j.cca.2025.120816_bb0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/chromsci\/bmz001","article-title":"Development and validation of simple LC-MS-MS assay for the quantitative determination of ticagrelor in human plasma: its application to a bioequivalence study","volume":"57","author":"Chae","year":"2019","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.cca.2025.120816_bb0130","author":"ICH"},{"issue":"2","key":"10.1016\/j.cca.2025.120816_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40262-013-0105-2","article-title":"Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases","volume":"53","author":"Kara\u017aniewicz-\u0141ada","year":"2014","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.cca.2025.120816_bb0140","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0002-8223(01)00337-6","article-title":"Salicylic acid: one more reason to eat your fruits and vegetables","volume":"101","author":"Scheier","year":"2001","journal-title":"J. Am. Diet. Assoc."},{"issue":"3\u20134","key":"10.1016\/j.cca.2025.120816_bb0145","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000488348","article-title":"Which fruits and vegetables should be excluded from a low-salicylate diet? An analysis of salicylic acid in foodstuffs in Taiwan","volume":"176","author":"Chiang","year":"2018","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"17","key":"10.1016\/j.cca.2025.120816_bb0150","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1074\/jbc.M112.427674","article-title":"Aspirin hydrolysis in plasma is a variable function of butyrylcholinesterase and platelet-activating factor acetylhydrolase 1b2 (PAFAH1b2)","volume":"288","author":"Zhou","year":"2013","journal-title":"J. Biol. Chem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:28:22Z","timestamp":1793640502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125006953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"alternative-id":["S0009898125006953"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120816","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification of acetylsalicylic acid, clopidogrel, ticagrelor and their major metabolites in human plasma by liquid chromatography\u2013tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120816"}}